Research News & Trainings | |
Facts and Snacks-Meet your
Proposal Development Office (PDO) Liaison
Date: TODAY Tuesday, Sept. 12
Time: 12-1 p.m. EST
Where: Zoom
Registration for in person attendance has closed, but you can still join us on Zoom for this important presentation!
Please visit the events page to access the Zoom link as well as read more about our PDO liaison, Marjorie Stanek.
| |
|
The Society of Postdoctoral Scholars (SOPS) at the University of Kentucky (UK) is hosting their Annual Research & Career Symposium to showcase the work of UK postdoctoral scholars and fellows, promote networking among the UK research community, and encourage discussions on career paths for postdocs and PhD students.
This year, the symposium will be held in person at the Gatton Student Center on September 21, 2023. Read more about the symposium here.
You can reach out to Joseph Lutz (joseph.lutz@uky.edu) with any questions. Registration closes on September 15th.
| |
|
Requests for Applications: KL2 Career Development Program
The Center for Clinical and Translational Science (CCTS) at the University of Kentucky has funds available through an NIH CTSA KL2 award to support junior faculty committed to developing academic careers focused on clinical and/or translational research/science.
Junior faculty from any college at the University of Kentucky are eligible to apply. Applications from underrepresented minorities and those with disabilities and/or having disadvantaged backgrounds are highly encouraged to apply.
Letter of Intent Due: Wednesday, September 20, 2023 by 5 pm
Informational Meeting: Monday, September 25, 2023, 5-6 pm
Applications Due: Monday, November 13, 2023 by 5 pm
| |
|
Improving Methods for Conducting Patient-Centered Outcomes Research -- 2023 Standing PFA (Cycle 3 2023)
Agency
Patient-Centered Outcomes Research Institute (PCORI)
Description
PCORI seeks to fund projects that address important methodological gaps and lead to improvements in the strength and quality of evidence generated by comparative effectiveness research (CER) studies. For the 2023 Methods PFA, PCORI has identified the following areas as programmatic priorities:
- Methods to Improve the Use of Artificial Intelligence (AI) and Machine Learning (ML) in Clinical Research
- Methods to Improve Study Design
- Methods to Support Data Research Networks
- Methods Related to Ethical and Human Subjects Protections Issues in CER
Important Dates
Application Available: September 6, 2023
Letter of Intent Due: October 3, 2023
Full Application Due: January 9, 2024
NOTE: This is a Forecasted Opportunity.
| |
|
Firearm Injury Prevention in Community Healthcare Settings (R01 Clinical Trial Optional)
Agency
NIH
Description
The purpose of this initiative is to advance research that reduces firearm injury and disparities through the development and evaluation of firearm injury primary prevention interventions leveraging community healthcare settings.
This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP), which will be assessed as part of the scientific and technical peer review evaluation. Applications that fail to include a PEDP will be considered incomplete and will be withdrawn.
Activity Code
R01 Research Project Grant
Announcement Number:
RFA-NR-24-001
Closing Date
November 7th, 2023; July 26, 2024
| |
|
Grants to Support New Investigators in Conducting Research Related to Understanding Drug Use and Overdose Risk and Protective Factors (K01)
Agency
CDC
Description
The purpose of the Centers for Disease Control and Prevention National Center for Injury Prevention and Control (NCIPC) Mentored Research Scientist Development Award (K01) is to provide support for an intensive, supervised/mentored career development experience in substance use and/or overdose prevention research leading to research independence. NCIPC supports K01 grants to help ensure the availability of an adequate number of trained scientists to address critical public health research questions to prevent polydrug use and overdose. This funding would support research that aims to better understand and identify risk and protective factors related to any drug use/overdose (e.g., opioids including fentanyl and stimulants, etc.), substance use disorders (SUDs), and stigma (e.g., how do certain factors impact stigma). Research can focus on the examination of potential moderators or mediators between the relationship between risk and protective factors and drug use and outcomes.
Activity Code
K01
Announcement Number
RFA-CE-24-011
Closing Date
December 01, 2023
| |
|
Rigorous Evaluation of Policy-Level Interventions to Prevent Overdose (R01)
Agency
CDC
Description
The Centers for Disease Control and Prevention’s (CDC) National Center for Injury Prevention and Control (NCIPC, Injury Center) is soliciting investigator-initiated research to rigorously evaluate effectiveness of policies for reducing drug use and overdose as well as the effect of these strategies on reducing or worsening existing disparities in medical care and health outcomes. Equally important to quantifying the impacts of these policies on health outcomes is understanding their implementation and how implementation affects achieving the intended outcomes of the policy among groups experiencing disproportionate burden of overdose and/or groups that are at greater risk of experiencing adverse outcomes related to substance use due to social determinants of health. The proposed research should evaluate the impact of a selected local, state, tribal, federal, or organizational policy (e.g., school or health systems) aimed at reducing or regulating substance use or reducing drug overdose, on rates of at least two overdose outcomes (i.e., nonfatal overdose, fatal overdose, substance use disorders, substance use, initiation of substance use among youth).
Activity Code
R01
Announcement Number
RFA-CE-24-012
Closing Date
December 1, 2023
| |
|
Research Grants to Identify Effective Community Based Strategies for Overdose Prevention (R01)
Agency
CDC
Description
The Centers for Disease Control and Prevention’s (CDC) National Center for Injury Prevention and Control (NCIPC, Injury Center) is soliciting investigator-initiated research to partner with communities to develop and rigorously evaluate the effectiveness of new, innovative, under-developed, or untested community-based strategies/interventions/programs/practices to reduce overdose. Strategies/interventions/programs/practices may include, but are not limited to, those that focus on preventing drug use initiation and drug use, reducing non-infectious harms related to drug use, reducing stigma or other barriers to harm reduction or substance use disorder treatment, and increasing linkage to and retention in care. Research should focus on groups experiencing disproportionate burden of overdose and/or groups that are at greater risk of experiencing adverse outcomes related to substance use. Research should also involve engaging individuals in the focus population (e.g., people with lived experience with substance use).
Activity Code
R01
Announcement Number
RFA-CE-24-013
Closing Date
December 1, 2023
| | | | |
